Browse by author
Lookup NU author(s): Dr James Orr, Tara HomerORCiD, Professor Laura Ternent, Emerita Professor Julia Newton, Emeritus Professor Calum McNeilORCiD, Dr Mark Hudson, Professor David Jones
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Cirrhosis has a long natural history with considerable symptomatic impacts, particularly in advancing disease. Measuring health related quality of life (HRQOL) in liver disease provides detail about the nature and extent of its effects on individuals. Understanding the drivers of impaired HRQOL can help identify targets for improvement through new treatments or health systems service delivery. Evaluation of novel therapies which target symptomatic improvement, should be done with suitable outcome measures, including HRQOL assessment. In this article, we provide an overview of HRQOL in advanced liver disease for the clinician. A clear description of the important HRQOL tools is given alongside a discussion of the factors, which are known to contribute to impaired HRQOL in advanced liver disease. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Author(s): Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DEJ
Publication type: Review
Publication status: Published
Journal: Journal of Hepatology
Year: 2014
Volume: 61
Issue: 5
Pages: 1158-1165
Print publication date: 01/11/2014
Online publication date: 07/07/2014
Acceptance date: 30/06/2014
ISSN (print): 0168-8278
ISSN (electronic): 1600-0641
Publisher: ELSEVIER SCIENCE BV
URL: http://dx.doi.org/10.1016/j.jhep.2014.06.034
DOI: 10.1016/j.jhep.2014.06.034